Pavan, L., Ruocco, V., Berno, T., carabotta, V., Hu, X., Massarotti, L., Vavolo, L., Zatta, I., Barila, G., Scomazzon, E., Furlan, A., Febbo, M. A., Clissa, C., Paolini, R., March, E. D., Sbisà, E., Caizzi, M., Trentin, L., Zambello, R. (2025). Daratumumab, bortezomib, thalidomide and dexamethasone improves renal outcomes in multiple myeloma transplant eligible patients presenting with renal failure: A real life experience from northeastern Italy. Blood. https://doi.org/10.1182/blood-2025-2285